Beta-Sitosterol Alters Collagen Distribution in Prostate Fibroblasts

References

• Awad AB, Burr AT, Fink CS. 2005. Effect of resveratrol and beta-sitosterol in combination on reactive oxygen species and prostaglandin release by PC-3 cells. Prostaglandins Leukot Essent Fatty Acids. 72(3):219–226. doi: 10.1016/j.plefa.2004.11.005.
   PubMed Web of Science ®Google Scholar
• Awad AB, Fink CS, Williams H, Kim U. 2001. In vitro and in vivo (SCID mice) effects of phytosterols on the growth and dissemination of human prostate cancer PC-3 cells. Eur J Cancer Prev. 10(6):507–513. doi: 10.1097/00008469-200112000-00005.
   PubMed Web of Science ®Google Scholar
• Begley L, Keeney D, Beheshti B, Squire JA, Kant R, Chaib H, MacDonald JW, Rhim J, Macoska JA. 2006. Concordant copy number and transcriptional activity of genes mapping to derivative chromosomes 8 during cellular immortalization in vitro. Genes Chromosomes Cancer. 45(2):136–146. doi: 10.1002/gcc.20274.
   PubMed Web of Science ®Google Scholar
• Begley LA, Kasina S, MacDonald J, Macoska JA. 2008. The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy. Cytokine. 43(2):194–199. doi: 10.1016/j.cyto.2008.05.012.
   PubMed Web of Science ®Google Scholar
• Cole C, Burgoyne T, Lee A, Stehno-Bittel L, Zaid G. 2015. Arum Palaestinum with isovanillin, linolenic acid and beta-sitosterol inhibits prostate cancer spheroids and reduces the growth rate of prostate tumors in mice. BMC Complement Altern Med. 15(1):264. doi: 10.1186/s12906-015-0774-5.
   PubMedGoogle Scholar
• Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J. 2008. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLOS Biol. 6(12):2853–2868. doi: 10.1371/journal.pbio.0060301.
   PubMed Web of Science ®Google Scholar
• D’Arcy Q, Gharaee-Kermani M, Zhilin-Roth A, Macoska JA. 2022. The IL-4/IL-13 signaling axis promotes prostatic fibrosis. PLOS One. 17(10):e0275064. doi: 10.1371/journal.pone.0275064.
   PubMed Web of Science ®Google Scholar
• Gharaee-Kermani M, Kasina S, Moore BB, Thomas D, Mehra R, Macoska JA. 2012. CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis. PLOS One. 7(11):e49278. doi: 10.1371/journal.pone.0049278.
   PubMed Web of Science ®Google Scholar
• Gharaee-Kermani M, Moore BB, Macoska JA. 2016. Resveratrol-mediated repression and reversion of prostatic myofibroblast phenoconversion. PLOS One. 11(7):e0158357. doi: 10.1371/journal.pone.0158357.
   PubMed Web of Science ®Google Scholar
• Laborde EE, McVary KT. 2009. Medical management of lower urinary tract symptoms. Rev Urol. 11(Suppl 1):S19–S25.
   PubMedGoogle Scholar
• Macoska JA, Leverson G, McVary KT, Ricke WA. 2019. Prostate Transition Zone Fibrosis in Men who Who Failed Doxazosin, Finasteride, or Combination Therapy in the Medical Therapy of Prostatic Symptoms (MTOPS) Submitted. J. Urol. 202: 1–8.
   Google Scholar
• Marks LS, Partin AW, Epstein JI, Tyler VE, Simon I, Macairan ML, Chan TL, Dorey FJ, Garris JB, Veltri RW, et al. 2000. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. J Urol. 163(5):1451–1456. doi: 10.1016/S0022-5347(05)67641-0.
   PubMed Web of Science ®Google Scholar
• Patalano S, Rodriguez-Nieves J, Colaneri C, Cotellessa J, Almanza D, Zhilin-Roth A, Riley T, Macoska J. 2018. CXCL12/CXCR4-mediated procollagen secretion is coupled to cullin-RING ubiquitin ligase activation. Sci Rep. 8(1):3499. doi: 10.1038/s41598-018-21506-7.
   PubMedGoogle Scholar
• Petrangeli E, Lenti L, Buchetti B, Chinzari P, Sale P, Salvatori L, Ravenna L, Lococo E, Morgante E, Russo A, et al. 2009. Lipido-sterolic extract of Serenoa repens (LSESr, Permixon) treatment affects human prostate cancer cell membrane organization. J Cell Physiol. 219(1):69–76. doi: 10.1002/jcp.21648.
   PubMed Web of Science ®Google Scholar
• Pradhan N, Parbin S, Kausar C, Kar S, Mawatwal S, Das L, Deb M, Sengupta D, Dhiman R, Patra SK. 2019. Paederia foetida induces anticancer activity by modulating chromatin modification enzymes and altering pro-inflammatory cytokine gene expression in human prostate cancer cells. Food Chem Toxicol. 130:161–173. doi: 10.1016/j.fct.2019.05.016.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Nieves JA, Macoska JA. 2013. Prostatic fibrosis, lower urinary tract symptoms, and BPH. Nat Rev Urol. 10(9):546–550. doi: 10.1038/nrurol.2013.149.
   PubMed Web of Science ®Google Scholar
• Sato K, Nakano A. 2007. Mechanisms of COPII vesicle formation and protein sorting. FEBS Lett. 581(11):2076–2082. doi: 10.1016/j.febslet.2007.01.091.
   PubMed Web of Science ®Google Scholar
• Smith T, Majid F, Eckl V, Reynolds C. 2021. Herbal supplement sales in us increase by record-breaking 17.3% in 2020. HerbalGram Fall. 2021(131):52–65.
   Google Scholar
• Stone KR, Mickey DD, Wunderli H, Mickey and GH, Paulson DF. 1978. Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer. 21(3):274–281. doi: 10.1002/ijc.2910210305.
   PubMed Web of Science ®Google Scholar
• Strope SA, Yang L, Nepple KG, Andriole GL, Owens PL. 2012. Population based comparative effectiveness of transurethral resection of the prostate and laser therapy for benign prostatic hyperplasia. J Urol. 187(4):1341–1345. doi: 10.1016/j.juro.2011.11.102.
   PubMed Web of Science ®Google Scholar
• Sudeep HV, Venkatakrishna K, Amrutharaj B, Shyamprasad K, Anitha. 2019. A phytosterol-enriched saw palmetto supercritical CO(2) extract ameliorates testosterone-induced benign prostatic hyperplasia by regulating the inflammatory and apoptotic proteins in a rat model. BMC Complement Altern Med. 19(1):270. doi: 10.1186/s12906-019-2697-z.
   PubMed Web of Science ®Google Scholar
• Sultan C, Terraza A, Devillier C, Carilla E, Briley M, Loire C, Descomps B. 1984. Inhibition of androgen metabolism and binding by a liposterolic extract of “Serenoa repens B” in human foreskin fibroblasts. J Steroid Biochem. 20(1):515–519. doi: 10.1016/0022-4731(84)90264-4.
   PubMedGoogle Scholar
• Vacherot F, Azzouz M, Gil-Diez-De-Medina S, Colombel M, De La Taille A, Lefrere Belda MA, Abbou CC, Raynaud JP, Chopin DK. 2000. Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon in benign prostatic hyperplasia). Prostate. 45(3):259–266. doi: 10.1002/1097-0045(20001101)45:3<259::AID-PROS9>3.0.CO;2-G.
   PubMed Web of Science ®Google Scholar
• Vickman RE, Franco OE, Moline DC, Vander Griend DJ, Thumbikat P, Hayward SW. 2020. The role of the androgen receptor in prostate development and benign prostatic hyperplasia: a review. Asian J Urol. 7(3):191–202. doi: 10.1016/j.ajur.2019.10.003.
   PubMed Web of Science ®Google Scholar
• von Holtz RL, Fink CS, Awad AB. 1998. beta-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells. Nutr Cancer. 32(1):8–12. doi: 10.1080/01635589809514709.
   PubMed Web of Science ®Google Scholar